Skip to main content
Premium Trial:

Request an Annual Quote

Helicos Shares Rise on Instrument Sale

NEW YORK (GenomeWeb News) – Shares of Helicos BioSciences climbed around 16 percent in early trade on the Nasdaq after the firm announced that it had sold one of its Helicos Genetic Analysis Systems to the Turku Centre for Biotechnology in Turku, Finland.

The firm's shares were up $.18 at $1.30 less than an hour after the market opened.

The Turku Centre for Biotechnology's purchase represents the 10th sale of Helicos' HeliScope Single Molecule Sequencer. According to Helicos, there are 12 Helicos systems currently installed and operating at customer sites around the world.

Ron Lowy, Helicos' CEO, said in a statement that the firm averaged one placement per month during 2009 for the Helicos system.

The Scan

UK Pilot Study Suggests Digital Pathway May Expand BRCA Testing in Breast Cancer

A randomized pilot study in the Journal of Medical Genetics points to similar outcomes for breast cancer patients receiving germline BRCA testing through fully digital or partially digital testing pathways.

Survey Sees Genetic Literacy on the Rise, Though Further Education Needed

Survey participants appear to have higher genetic familiarity, knowledge, and skills compared to 2013, though 'room for improvement' remains, an AJHG paper finds.

Study Reveals Molecular, Clinical Features in Colorectal Cancer Cases Involving Multiple Primary Tumors

Researchers compare mismatch repair, microsatellite instability, and tumor mutation burden patterns in synchronous multiple- or single primary colorectal cancers.

FarGen Phase One Sequences Exomes of Nearly 500 From Faroe Islands

The analysis in the European Journal of Human Genetics finds few rare variants and limited geographic structure among Faroese individuals.